{"nct_id":"NCT05064358","title":"Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-03-03","start_date_type":"ACTUAL","primary_completion_date":"2024-08-19","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}